Predicción del deterioro cognitivo en ancianos mediante el análisis del rendimiento en fluidez verbal y en atención sostenida

Pérez-Díaz, Ángel G. López; Calero, M. Dolores; Navarro, Elena

doi:10.33588/rn.5601.2012281

Cited by 19 publications

(10 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Next, the participants were assessed using three validated screening tests: Memory Impairment Screening (MIS) (Böhm et al, 2005) (López et al, 2013).…”

Section: Data Collection and Statistical Treatmentmentioning

confidence: 99%

“…SFV is widely used in neuropsychological evaluation because is an instrument which is easy and fast to apply. It is very sensitive (74%) and specific (80%), allowing to differentiate with enough precision between subjects with and without dementia at the recommended cut-off score (10 words) (Price et al, 2012;López et al, 2013).…”

Section: Semantic Verbal Fluencymentioning

confidence: 99%

See 1 more Smart Citation

Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate

Ramos

Pardo²,

Sánchez³

et al. 2021

Front. Pharmacol.

View full text Add to dashboard Cite

The increased pressure on primary care makes it important for other health care providers, such as community pharmacists, to collaborate with general practitioners in activities related to chronic disease care. Therefore, the objective of the present project was to develop a protocol of action that allows close pharmacist-physician collaboration to carry out a coordinated action for very early detection of cognitive impairment (CI).Methods: A comparative study to promote early detection of CI was conducted in 19 community pharmacies divided into two groups: one group with interprofessional collaboration (IPC) and one group without interprofessional collaboration (NonIPC). IPC was defined as an interactive procedure involving all pharmacists, general practitioners and neurologists. A total of 281 subjects with subjective memory complaints were recruited. Three tests were used in the community pharmacies to detect possible CI: Memory Impairment Screening, Short Portable Mental State Questionnaire, and Semantic Verbal Fluency. Individuals with at least one positive cognitive test compatible with CI, were referred to primary care, and when appropriate, to the neurology service. Finally, we evaluated the differences in clinical and diagnostic follow-up in both groups after six months.Results: The NonIPC study group included 38 subjects compatible with CI referred to primary care (27.54%). Ten were further referred to a neurology department (7.25%) and four of them (2.90%) obtained a confirmed clinical diagnosis of CI. In contrast, in the IPC group, 46 subjects (32.17%) showed results compatible with CI and were referred to primary care. Of these, 21 (14.68%) were subsequently referred to a neurology service, while the remaining 25 were followed up by primary care. Nineteen individuals out of those referred to a neurology service obtained a confirmed clinical diagnosis of CI (13.29%). The percentage of subjects in the NonIPC group referred to neurology and the percentage of subjects diagnosed with CI, was significantly lower in comparison to the IPC group (p-value = 0.0233; p-value = 0.0007, respectively).Conclusions: The creation of IPC teams involving community pharmacists, general practitioners, and neurologists allow for increased detection of patients with CI or undiagnosed dementia and facilitates their clinical follow-up. This opens the possibility of diagnosis in patients in the very early stages of dementia, which can have positive implications to improve the prognosis and delay the evolution of the disease.

show abstract

“…Next, the participants were assessed using three validated screening tests: Memory Impairment Screening (MIS) (Böhm et al, 2005) (López et al, 2013).…”

Section: Data Collection and Statistical Treatmentmentioning

confidence: 99%

Section: Semantic Verbal Fluencymentioning

confidence: 99%

Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate

Ramos

Pardo²,

Sánchez³

et al. 2021

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

“…Three validated screening tests be completed with all the study variables in order to collect the largest number of factors related to CI. Specifically: Memory Impairment Screening (MIS) [11], Short Portable Mental State Questionnaire (SPMSQ) [12] and Semantic Verbal Fluency (FVS) [13]. The tests used have been chosen after consultation with the Valencian Society of SM.…”

Section: Data Collectionmentioning

confidence: 99%

Is the Internet Really Ruining Your Memory? Keep Reading as Modiﬁable Protective Factor Against Cognitive Impairment

Ramos¹,

Alacreu²,

Guerrero³

et al. 2020

Preprint

View full text Add to dashboard Cite

Subjective cognitive decline (SCD) would correspond to a preclinical phase of Alzheimer's disease. The aim of this study was to find associations between lifestyle individual factors compatible scores with cognitive impairment (CI) in SCD people. Methods: This is a case-control study to detect SCD, CI and potential associated factors in 497 patients over 50 years in Community Pharmacies. Three screening tests detected possible CI and patients with at least one test compatible with CI were referred to Primary Care to be evaluated. Results: In self-complaint patients statistically significant with depressive feelings were found (86.8%) with benzodiazepines consumers (83.9%) and female patients (81.2%). Thirty percent of our sample obtained scores compatible with CI. Being older than 70 years old increased the odds of obtaining scores compatible with CI. High level education, reading and internet use were able to reduce the odds of positive scores compatible with CI (37%-91%, 7%-18% and 67%-86%), whereas, one extra hour television/day increased the risk in 8%-30%. Reading was able to nullify the effect of both internet and TV consumption. Conclusion: Not just the age but also modifiable lifestyle factors are acting in favour of a cognitive decline.

show abstract

“…Questionnaire (SPMSQ) de Pfeiffer (15) Se utiliza la versión validada al castellano por Martínez de la Iglesia. Fluidez Verbal Semántica (FVS) (16) Se trata de una tarea simple de recuerdo de palabras de una categoría dada que consiste en pedirle a la persona que diga tantas palabras como pueda de la categoría "animales" por ejemplo. El evaluador anota las palabras válidas citadas por el evaluado durante un minuto.…”

Section: Short Portable Mental Stateunclassified

Proyecto CRIDECO: Cribado de deterioro cognitivo en farmacia comunitaria a partir de la queja subjetiva de memoria

Catalá¹,

Royo²,

Molinera³

et al. 2018

View full text Add to dashboard Cite

RESUMENObjetivo: desarrollar un programa de cribado de deterioro cognitivo (DC) en mayores de 50 años. Con la finalidad de que el servicio profesional farmacéutico sea más costo-efectivo utilizaremos un árbol de decisión para la selección del paciente.Además, se pretende valorar la importancia de la dieta mediterránea y el consumo de antioxidantes en la prevención del deterioro cognitivo y estudiar marcadores genéticos de riesgo de enfermedad de Alzheimer.Método: para ello se diseña un estudio observacional transversal mediante entrevista personal estructurada en pacientes que muestren indicios de pérdida de memoria. El estudio de captación se realizará en farmacias desde septiembre 2018 hasta septiembre de 2019. Los pacientes con puntuación en los test con posible DC se remitirán a atención primaria, previa presentación del proyecto a coordinación médica. Se perseguirá el resultado del diagnóstico obtenido en atención primaria y/o especializada. Se utilizarán como test de cribado el Memory Impairment Screening (MIS), Short Portable Mental State Questionnaire (SPMSQ) de Pfeiffer, el Fluidez Verbal Semántica (FVS) y siempre que sea posible el Test del Informador (TIN). Se define deterioro cognitivo por MIS ≤4; SPMSQ ≥ 3 (para analfabetos ≥ 4); FVS ≤10 palabras y el valor del TIN >57. A su vez se recogen una muestra de saliva del paciente, para estudio genético, y datos de nutrición para valorar la importancia de la dieta mediterránea y de los alimentos antioxidantes en la prevención del DC. CRIDECO Project. Screening for cognitive impairment in community pharmacy based on subjective memory complaint ABSTRACTThe aim of this study is to develop a screening program for cognitive impairment (CI) in people older than 50 year old. In order to make the pharmaceutical professional service more cost-effective, we will use a decision tree for patient's selection.In addition, to assess the importance of the Mediterranean diet and the consumption of antioxidants in the prevention of cognitive deterioration and study genetic markers of risk of Alzheimer's disease.

show abstract

Predicción del deterioro cognitivo en ancianos mediante el análisis del rendimiento en fluidez verbal y en atención sostenida

Cited by 19 publications

References 24 publications

Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate

Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate

Is the Internet Really Ruining Your Memory? Keep Reading as Modiﬁable Protective Factor Against Cognitive Impairment

Proyecto CRIDECO: Cribado de deterioro cognitivo en farmacia comunitaria a partir de la queja subjetiva de memoria

Contact Info

Product

Resources

About